Therapeutic targeting of transport-mediated resistance Given the central role of efflux transporters in mediating MDR, extensive efforts have been dedicated to the development of pharmacological strategies aimed at overcoming transporter-driven drug efflux
GlyNAC in older adults: The most compelling evidence for glutathione supplementation in aging comes from the GlyNAC studies by Kumar et al
orange, apple, mandarin, guava, papaya, lime, mango, pineapple, grape, l-ascorbic acid, zinc gluconate, natural orange flavor, citric acid, sucrose, cholecalciferol (vegan, lichen source), freshness preserver (potassium sorbate, sodium benzoate), beta carotene
So Im not sure exactly what they have lower rates of death from
A small number of patients might experience temporary discomfort where they were injected or have mild symptoms like headaches or nausea